Rx Evolution: An Ununified Model of MDD and Pharmacological Paradigms
Keep the Cart Behind the Horse: Privilege and Responsibility as a Provider
Remember to keep the cart behind the horse while practicing medicine.
Rx Evolution: Pharmacological Paradigms for the Treatment of Schizophrenia
We remain challenged to improve treatments and outcomes in schizophrenia. Explore the latest options.
Reflections on Christmases Past
What is most memorable about your childhood holiday celebrations?
Looking Back on 100 Years Ago
What happened in 1922, and how do these events look 100 years later?
Is Science Drifting Into the Dark Ages?
"The cog in the wheel of treatment today is misinformation and lack of trust in the institutions of medicine, peer-reviewed published literature, the CDC, and pharmaceutical research."
"As clinicians who took an oath to 'do no harm,' we must educate the public about the dangers and non–standard of care of the growing practice of at-home ketamine."
Confusing the Diagnosis for the Person
Missing out on treating a person rather than a diagnosis?
Serotonin: A Biography
"It would be naïve to believe that targeting a single neurotransmitter, receptor, or circuit in the brain will cure any psychiatric or neurological disorder. However, we would be remiss if we did not try."
Figures for Serotonin: A Biography
These are the extra figures for John J. Miller, MD's article, "Serotonin: A Biography" from the 2022 September issue.
Cannabis: Separating the Conversation on CBD and THC
CBD and THC? What's the difference and why does it matter?
Psilocybin: The Complicated Conversation
The resistance against "magic mushrooms"—is it justified?
Taking a Deeper Dive Into the Cannabis Story
Here's why more research is important to help us better understand the effects of cannabis on our patients.
Everyone Please Stop (EPS)
Is the term, "extrapyramidal symptoms," an example of a “4-letter word”?
Psychiatric Pharmacogenomics: The Evidence Base
"The young and exciting field of psychiatric pharmacogenomics is providing a third pillar of understanding to aid in our competent and informed prescribing of drugs, joining the more well-established pillars of pharmacokinetics and pharmacodynamics."
New 988 Suicide Hotline: Thoughts From the Editor in Chief
What does the Psychiatric Times Editor in Chief think about 988?
Navigating to a Broader Population of First-Episode Patients
What are the benefits of early and comprehensive intervention for patients in their first episode of a serious mental illness?
The Benefits of Being in Person at the 2022 APA Annual Meeting
Our Editor in Chief is thrilled to be live and in person at the 2022 APA Annual Meeting in New Orleans. Here's why.
The Importance of Psychosocial Stress Explored at the 2022 APA Annual Meeting
How do social stressors contribute to patient symptoms?
A Dangerous Evolution?
There have been many exciting advances in telemedicine in recent years. But does telemedicine really allow us to be genuinely present for our patients?
Learn With Us in San Diego
The 2022 Annual Psychiatric Times World CME Conference is coming in August.
Movements in the 4th Dimension
Take a look at the 4 primary movement disorders commonnly encountered in psychiatry when antipsychotics are prescribed.
Patient Discussion and the Importance of Continuous Patient Education
How can you empower the patient to be part of the discussion surrounding their treatment?
Once again it is time to embrace a new DSM. What can we expect from this new version?
The Next Iteration of DSM
DSM-5-TR is here.
10 Factors to Consider When Cross-Titrating Antipsychotics
In this CME article, familiarize yourself with various pharmacokinetic, pharmacodynamic, and patient-specific factors to review to develop a successful cross-titration plan from one antipsychotic to another.
Neuroplasticity and Smart Phones
Smart phones have the potential to be either a useful and highly constructive asset or a destructive and harmful diversion from life.
The Illicit Fentanyl Russian Roulette
Playing with opioids is a dangerous game...
The Opioid Epidemic Is Alive—And Unwell
This is the sad reality: In the first year of COVID-19, there were 20,000 more opioid overdose deaths than years previous.
Hope for the New Year
The glass is half full: reflections on where we are and hope for where we are heading in psychiatry.
2 Clarke Drive Cranbury, NJ 08512